Results 41 to 50 of about 159,299 (261)

Emerging insights into CC and CXC chemokines and their receptors in Mycobacterium tuberculosis infection

FEBS Open Bio, EarlyView.
The dual roles of CC and CXC chemokines in distinguishing active, latent, and subclinical tuberculosis were reviewed, along with an evaluation of their potential as diagnostic biomarkers and therapeutic targets to advance precision medicine in tuberculosis management. The graphical abstract was generated with AI assistance (Gemini 3.0).
Xuying Yin, Dangsheng Xiao, Jiezuan Yang
wiley   +1 more source

Early and Late Influenza Vaccine Effectiveness in South Korea During the 2023–2024 Season

Vaccines
Background: During the 2023–2024 season, the influenza epidemic in South Korea peaked earlier, and the influenza vaccination rate among individuals aged ≥ 65 was high (82.2%).
Yu Jung Choi, Joon Young Song, Seong-Heon Wie, Jacob Lee, Jin-Soo Lee, Hye Won Jeong, Joong Sik Eom, Jang Wook Sohn, Won Suk Choi, Eliel Nham, Jin Gu Yoon, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim   +13 more
doaj   +1 more source

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong

Human Vaccines & Immunotherapeutics, 2020
In Hong Kong, universal varicella vaccination was introduced in July 2014 with a two-dose schedule but the vaccines had been available in the private market since 1996.
Yung-Wai Desmond Chan, W John Edmunds, Hong-Lam Chan, Miu-Ling Wong, Ka-Wing Albert Au, Shuk-Kwan Chuang, Albert Jan van Hoek, Stefan Flasche   +7 more
doaj   +1 more source

Influenza Vaccine Effectiveness against Hospitalization, Season 2021/22: A Test-Negative Design Study in Barcelona

Vaccines, 2023
Background: Vaccination is considered the most effective measure for preventing influenza and its complications. The influenza vaccine effectiveness (IVE) varies annually due to the evolution of influenza viruses and the update of vaccine composition ...
Mar Fornaguera, Oleguer Parés-Badell, Íngrid Carbonés-Fargas, Cristina Andrés, José Ángel Rodrigo-Pendás, Blanca Borras-Bermejo, Lluís Armadans-Gil, Gabriela Tejada, David Guananga, Martí Vivet-Escalé, Arnau Peñalver-Piñol, Irene Torrecilla-Martínez, Arnau del Oso, Xavier Martínez-Gómez, Andres Antón, Susana Otero-Romero   +15 more
doaj   +1 more source

Vaccination side effects [PDF]

British Dental Journal, 2021
Dziedzic, A., Tanasiewicz, M.
openaire   +2 more sources

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock, Jin Nakahara, Becky Parks, Kerstin Allen, Sami Fam   +4 more
wiley   +1 more source

A global living systematic review and meta-analysis hub of emerging vaccines in pregnancy and childhood

Reproductive Health
The COVID-19 pandemic accelerated vaccine development and generated a rapidly evolving body of evidence before and after the vaccine rollout. We developed a robust online platform to efficiently synthesize this emerging information for current and future
Agustín Ciapponi, Ariel Bardach, Mabel Berrueta, Jamile Ballivian, Martin Brizuela, Julieta Caravario, Noelia Castellana, Daniel Comande, Esteban Couto, Agustina Mazzoni, Vanesa Ortega, Edward P. K. Parker, Juan M. Sambade, Salva Florencia, Juan Pablo Smutny, Katharina Stegelmann, Xu Xiong, Andy Stergachis, Flor M. Munoz, Pierre Buekens   +19 more
doaj   +1 more source

Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018

Human Vaccines & Immunotherapeutics
While the number of immunocompromised (IC) individuals continues to rise, the existing literature on influenza vaccine effectiveness (VE) in IC populations is limited.
Kailey Hughes Kramer, Richard K. Zimmerman, Catherine L. Haggerty, G. K. Balasubramani, Mary Patricia Nowalk, Emily T. Martin, Manjusha Gaglani, C. Hallie Phillips, Edward Belongia, Jessie Chung, Fernanda P. Silveira   +10 more
doaj   +1 more source

Vaccine epidemiology, evaluation, and constraints of vaccine effectiveness -A review

Veterinary Vaccine, 2022
Vaccines are all biological substances produced from living things, administered to trigger the host's body defense system to develop immunity against a specific pathogen from which they are produced.
Habtamu Endale, Saliman Aliye, Mesfin Mathewos   +2 more
doaj   +1 more source